These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 9177383)
1. Studies of the impact of a liver glucokinase promoter variant on glucose tolerance and insulin sensitivity index. Urhammer SA; Hansen T; Jensen LB; Clausen JO; Hansen L; Chui KC; Pedersen O J Clin Endocrinol Metab; 1997 Jun; 82(6):1786-9. PubMed ID: 9177383 [TBL] [Abstract][Full Text] [Related]
2. Glucokinase gene islet promoter region variant (G-->A) at nucleotide -30 is not associated with reduced insulin secretion in Finns. Rissanen J; Saarinen L; Heikkinen S; Kekäläinen P; Mykkänen L; Kuusisto J; Deeb SS; Laakso M Diabetes Care; 1998 Jul; 21(7):1194-7. PubMed ID: 9653619 [TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of Japanese men with glucokinase gene beta-cell promoter variant. Yamada K; Yuan X; Ishiyama S; Ichikawa F; Koyama KI; Koyanagi A; Koyama W; Nonaka K Diabetes Care; 1997 Jul; 20(7):1159-61. PubMed ID: 9203455 [TBL] [Abstract][Full Text] [Related]
4. Promoter variation in the liver glucokinase is a risk factor for non-insulin-dependent diabetes mellitus. Chiu KC; McCarthy JE Biochem Biophys Res Commun; 1996 Apr; 221(3):614-8. PubMed ID: 8630009 [TBL] [Abstract][Full Text] [Related]
5. A variation at position -30 of the beta-cell glucokinase gene promoter is associated with reduced beta-cell function in middle-aged Japanese-American men. Stone LM; Kahn SE; Fujimoto WY; Deeb SS; Porte D Diabetes; 1996 Apr; 45(4):422-8. PubMed ID: 8603762 [TBL] [Abstract][Full Text] [Related]
6. Glucokinase gene variants in subjects with late-onset NIDDM and impaired glucose tolerance. Laakso M; Malkki M; Kekäläinen P; Kuusisto J; Mykkänen L; Deeb SS Diabetes Care; 1995 Mar; 18(3):398-400. PubMed ID: 7555485 [TBL] [Abstract][Full Text] [Related]
7. Analysis of the glucokinase gene promoter in Japanese subjects with noninsulin-dependent diabetes mellitus. Shimokawa K; Sakura H; Otabe S; Eto K; Kadowaki H; Hagura R; Yazaki Y; Akanuma Y; Kadowaki T J Clin Endocrinol Metab; 1994 Sep; 79(3):883-6. PubMed ID: 8077376 [TBL] [Abstract][Full Text] [Related]
8. A new variant in the human Kv1.3 gene is associated with low insulin sensitivity and impaired glucose tolerance. Tschritter O; Machicao F; Stefan N; Schäfer S; Weigert C; Staiger H; Spieth C; Häring HU; Fritsche A J Clin Endocrinol Metab; 2006 Feb; 91(2):654-8. PubMed ID: 16317062 [TBL] [Abstract][Full Text] [Related]
9. Homozygosity for a common polymorphism in the islet-specific promoter of the glucokinase gene is associated with a reduced early insulin response to oral glucose in pregnant women. Zaidi FK; Wareham NJ; McCarthy MI; Holdstock J; Kalloo-Hosein H; Krook A; Swinn RA; O'Rahilly S Diabet Med; 1997 Mar; 14(3):228-34. PubMed ID: 9088772 [TBL] [Abstract][Full Text] [Related]
10. Search for genetic variants of the SYNTAXIN 1A (STX1A) gene: the -352 A>T variant in the STX1A promoter associates with impaired glucose metabolism in an Italian obese population. Romeo S; Sentinelli F; Cavallo MG; Leonetti F; Fallarino M; Mariotti S; Baroni MG Int J Obes (Lond); 2008 Mar; 32(3):413-20. PubMed ID: 17912268 [TBL] [Abstract][Full Text] [Related]
11. Studies of relationships between the GLUT10 Ala206Thr polymorphism and impaired insulin secretion. Rose CS; Andersen G; Hamid YH; Glümer C; Drivsholm T; Borch-Johnsen K; Jørgensen T; Pedersen O; Hansen T Diabet Med; 2005 Jul; 22(7):946-9. PubMed ID: 15975113 [TBL] [Abstract][Full Text] [Related]
12. Common amino acid substitutions in insulin receptor substrate-4 are not associated with Type II diabetes mellitus or insulin resistance. Almind K; Frederiksen SK; Ahlgren MG; Urhammer S; Hansen T; Clausen JO; Pedersen O Diabetologia; 1998 Aug; 41(8):969-74. PubMed ID: 9726601 [TBL] [Abstract][Full Text] [Related]
13. G(-30)A polymorphism in the pancreatic promoter of the glucokinase gene associated with angiographic coronary artery disease and type 2 diabetes mellitus. März W; Nauck M; Hoffmann MM; Nagel D; Boehm BO; Koenig W; Rothenbacher D; Winkelmann BR Circulation; 2004 Jun; 109(23):2844-9. PubMed ID: 15173029 [TBL] [Abstract][Full Text] [Related]
14. Glucokinase gene polymorphisms: a genetic marker for glucose intolerance in a cohort of elderly Finnish men. McCarthy MI; Hitman GA; Hitchins M; Riikonen A; Stengård J; Nissinen A; Tuomilehto-Wolf E; Tuomilehto J Diabet Med; 1994 Mar; 11(2):198-204. PubMed ID: 8200207 [TBL] [Abstract][Full Text] [Related]
15. Glucokinase gene variations in Japanese-Americans with a family history of NIDDM. Stone LM; Kahn SE; Deeb SS; Fujimoto WY; Porte D Diabetes Care; 1994 Dec; 17(12):1480-3. PubMed ID: 7882822 [TBL] [Abstract][Full Text] [Related]
16. Pathogenic mechanism of type 2 diabetes in Ghanaians--the importance of beta cell secretion, insulin sensitivity and glucose effectiveness. Amoah AG; Owusu SK; Schuster DP; Osei K S Afr Med J; 2002 May; 92(5):377-84. PubMed ID: 12108171 [TBL] [Abstract][Full Text] [Related]
17. The influence of genetic variations in HHEX gene on insulin metabolism in the German MESYBEPO cohort. Pivovarova O; Nikiforova VJ; Pfeiffer AF; Rudovich N Diabetes Metab Res Rev; 2009 Feb; 25(2):156-62. PubMed ID: 19117022 [TBL] [Abstract][Full Text] [Related]
18. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study. Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M; J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514 [TBL] [Abstract][Full Text] [Related]
19. Association of the hormone sensitive lipase -60C > G variant with fasting insulin levels in healthy young men. Talmud PJ; Palmen J; Nicaud V; Tiret L; Nutr Metab Cardiovasc Dis; 2002 Aug; 12(4):173-7. PubMed ID: 12514936 [TBL] [Abstract][Full Text] [Related]
20. The inhibitory effect of recent type 2 diabetes risk loci on insulin secretion is modulated by insulin sensitivity. Haupt A; Guthoff M; Schäfer SA; Kirchhoff K; Machicao F; Gallwitz B; Staiger H; Stefan N; Fritsche A; Häring HU J Clin Endocrinol Metab; 2009 May; 94(5):1775-80. PubMed ID: 19258404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]